The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Bifidobacterium infantis35624 modulates host inflammatory processes beyond the gut
Open accessAbstract
Certain therapeutic microbes, including Bifidobacteria infantis (B. infantis) 35624 exert beneficial immunoregulatory effects by mimicking commensal-immune interactions; however, the value of these effects in patients with non-gastrointestinal inflammatory conditions remains unclear. In this study, we assessed the impact of oral administration of B. infantis 35624, for 6‒8 weeks on inflammatory biomarker and plasma cytokine levels in patients with ulcerative colitis (UC) (n = 22), chronic fatigue syndrome (CFS) (n = 48) and psoriasis (n = 26) in three separate randomized, double-blind, placebo-controlled interventions. Additionally, the effect of B. infantis 35624 on immunological biomarkers in healthy subjects (n = 22) was assessed. At baseline, both gastrointestinal (UC) and non-gastrointestinal (CFS and psoriasis) patients had significantly increased plasma levels of C-reactive protein (CRP) and the pro-inflammatory cytokines tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6) compared with healthy volunteers. B. infantis 35624 feeding resulted in reduced plasma CRP levels in all three inflammatory disorders compared with placebo. Interestingly, plasma TNF-α was reduced in CFS and psoriasis while IL-6 was reduced in UC and CFS. Furthermore, in healthy subjects, LPS-stimulated TNF-α and IL-6 secretion by peripheral blood mononuclear cells (PBMCs) was significantly reduced in the B. infantis 35624-treated groups compared with placebo following eight weeks of feeding. These results demonstrate the ability of this microbe to reduce systemic pro-inflammatory biomarkers in both gastrointestinal and non-gastrointestinal conditions. In conclusion, these data show that the immunomodulatory effects of the microbiota in humans are not limited to the mucosal immune system but extend to the systemic immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the immune modulation effect of B. infantis 35624 was extended to systemic level since it was effective in reducing inflammatory biomarkers in patients with non-gastrointestinal inflammatory processes, such as chronic fatigue syndrome and psoriasis [144]”
From Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis (2014) · cites this paper as [144]
In the citing paper
“The studies carried out with the strain 35624 show that it was effective in reducing the proinflammatory state of patients with IBD [142,143] , as well as with UC [144]”
From Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis (2014) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., Komaroff, A., & and International Chronic Fatigue Syndrome Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00009 · Cited by 4,969
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694 · cited 3×
“TNF-α and IL-6 are pro-inflammatory cytokines which are elevated in a variety of inflammatory conditions and involved in transcriptional regulation of CRP.25,36 They are not employed in clinical practice but both of these cytokines have been targeted by aggressive anti-cytokine biologic agent therapy in the treatment…”
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292
Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R., Benoist, C., & Mathis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.001 · Cited by 1,577 · cited 1×
“There is persuasive evidence from several sources indicating that the gut microbiota has an influence on the development and maintenance, not only of the mucosal,(1,2) but also the systemic immune response.(3,4) This raises the therapeutic vista of modifying the systemic immune response by enteric microbes.”
BackgroundRidker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
Inferences, questions and possibilities in Toll-like receptor signalling
Beutler, B. (2004) · Nature · doi:10.1038/nature02761 · Cited by 1,476
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323 · cited 1×
“There is persuasive evidence from several sources indicating that the gut microbiota has an influence on the development and maintenance, not only of the mucosal,(1,2) but also the systemic immune response.(3,4) This raises the therapeutic vista of modifying the systemic immune response by enteric microbes.”
BackgroundCai, Y., Zheng, H., Gong, W. J., Che, Y., & Jiang, B. (2011) · Hepatogastroenterology · doi:10.5754/hge11155 · Cited by 1,257
Flagged first, then by citations
Research works printed but not linked: 2
- Biljan D, 2009, Coll Antropol, 33, 83
- Federico A, 2009, Eur Rev Med Pharmacol Sci, 13, 285
Cited by
Sorted by citations
Items 401–448 of 448
Zusammenhänge zwischen Fatigue und Mikronährstoffen sowie Darmmikrobiom
Löffler, C. (2020) · InFo Hämatologie + Onkologie · doi:10.1007/s15004-020-8273-3
The problem of dehydration in pediatrics
Кramarov, S. O., Yevtushenko, V. V., Yevtushenko, О. М., Maevska, Y. A., & Babak, V. V. (2021) · CHILD`S HEALTH · doi:10.22141/2224-0551.16.4.2021.236909
Probiotics and their importance for human health
Ungureanu, V. (2021) · Medic ro · doi:10.26416/med.5.1.2021.4587
Single Strain Probiotic Bifidobacteria Approach in Health and Non-Health Fields
Bozkurt, H. S., & Bozkurt, H. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99712
Coronavirus infection and gut microbiota
Дамировна, С. Д., & Abdulkhakov, S. R. (2021) · Kazan medical journal · doi:10.17816/kmj2021-518
Skin Barrier, Microbiome and Psoriasis
Hirayama, A. L. D. S., Fonseca, D. C., & Romiti, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00033-4
Critical Inspection of the Gut–Brain–Skin Triangle and Its Modulation Through Probiotics
Chugh, P., Sood, S., & Dhar, M. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_2
Kawakami, T. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736437714.793571859
Gupta, T., Kaur, H., Kapila, S., & Kapila, R. (2021) · Research Square · doi:10.21203/rs.3.rs-533546/v1
Quigley, E. M. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734986666.793569667
Self-citationBrüssow, H. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734986666.793562125
The microbiome of patients with irritable bowel syndrome: pathophysiology and applied aspects
Korochanskaya, N. V. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-14-107-112
Warner, B., Rosa, B., Ndao, I., Tarr, P., Miller, J. P., England, S. K., Luby, J., Rogers, C., Hall-Moore, C., Bryant, R., et al. (2022) · medRxiv · doi:10.1101/2022.11.17.22282482
“to diminish inflammation and associated with breastfeeding [54].”
BackgroundCurrent trends and future perspectives of probiotics on human health: an overview
Mandal, S., & Mandal, N. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90113-0.00005-5
The Causal Relationship between Gut Microbiota and Acne: A Two-Sample Mendelian Randomization Study
顾, 昀. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361468
Probiotics as Curators of a Healthy Gut Microbiota
Mills, S., Murphy, A., Dinan, T. G., Cryan, J. F., Stanton, C., & Ross, R. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00006-0
Self-citationLuan, M., Niu, M., Yang, P., Han, D., Zhang, Y., Li, W., He, Q., Zhao, Y., Mao, B., Chen, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24186185
Role of regulatory T cells in pathogenesis and therapeutics of psoriasis
Chaudhari, A., Bharti, A. H., & Dwivedi, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13947-5.00024-5
The Role of Gut Microbiota in Psoriasis: Current Knowledge and Emerging Therapeutic Interventions
Memariani, H., & Memariani, M. (2024) · International Journal of Enteric Pathogens · doi:10.34172/ijep.5636
Gut microbiota biodiversity indices as markers of hyperandrogenemia in women of reproductive age
Igumnov, I. A., Belkova, N. L., Atalyan, A. V., Станиславовна, К. Е., Sholokhov, L. F., Belenkaia, L. V., Samarina, Y. M., Николаевна, Д. И., Лазарева, Л. М., Nadeliaeva, I. G., et al. (2024) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2024-9.4.2
Probiotics in the Prevention and Treatment of Psoriasis
Biswasroy, P., Pradhan, D., Pradhan, D. K., Rath, G., & Ghosh, G. (2024) · doi:10.1002/9781119896869.ch9
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_6
Ivashkin, V., Poluektova, E., & Mamieva, Z. (2024) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2024-34-5-47-58
Doi, M., Inoue, R., Hosomi, K., Park, J., Yumioka, H., Syauki, A. Y., Kageyama, S., Sakaue, H., Tanabe, K., Mizuguchi, K., et al. (2025) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2024.2431283
“49 Bifidobacterium breve reduced dextran sodium sulfate-induced colitis in rats and increased Treg cell responses.”
Revolucionando la Dermatología: Probióticos, Prebióticos y el Futuro de los Tratamientos de la Piel
Vázquez, M. D., la Hoya, Á. J. S.-D., Gómez, L. S. P., Blanco, L. L., & García, A. I. R. (2025) · Estudios y Perspectivas Revista Científica y Académica · doi:10.61384/r.c.a..v4i4.822
Effect of Gut Microbiome on Skin Microbiome
Krohn, I. K., Pessemier, B. D., & Callewaert, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-82689-4_11
Microecological aspects of relationship between skin microbiota and psoriasis
Arsenyeva, A. A., Lyamin, A. V., Migacheva, N. B., Orlov, E. V., & Alekseev, D. V. (2024) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2024.4.426-438
Zhao, Y., Liu, X., Song, P., Chen, Q., Yang, X., & Yu, W. (2025) · Current Microbiology · doi:10.1007/s00284-025-04390-z
den Broeck, L. V., de Azevedo, R. S., Fiuza, L. F. D. A., Batista, M. M., Cascabulho, C. M., de Velde, E. V., Calenbergh, S. V., Caljon, G., & Soeiro, M. D. N. C. (2025) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760250014
“…0 - 7 days before infection 75% - 100% reduction (40) Trypanosoma cruzi L. casei ATCC7469 Mouse 3-7 days before infection 75% - 100% reduction (31) Trypanosoma brucei brucei Saccharomyces cerevisiae Rat 28 days before infection Significantly lower (42) Probiotics - PB8 probiotics (composed of…”
Yu, P., Zhao, A., Zhan, M., Zhang, L., Yang, C., Zhao, Y., & Yang, X. (2025) · Foods · doi:10.3390/foods14193367
“SCFAs also act the G protein-coupled receptors (GPRs) to further suppress the NF-κ B pathway, providing an additional layer of systemic anti-inflammatory regulation [59].”
Probiotics: Novel Natural Rejuvenators for Skin’s Health
Sinhmar, N., Battan, B., Verma, S., Chahal, S., & Sharma, J. (2025) · Journal of Natural Remedies · doi:10.18311/jnr/2025/47791
Lin, Y., Fan, L., Qi, Y., Xu, C., Jia, D., Jiang, Y., Chen, S., & Wang, L. (2024) · Figshare · doi:10.6084/m9.figshare.26604793
Bosselaar, S., Dhelin, L., Dautel, E., Titécat, M., Duthoy, S., Stelmaszczyk, M., Delory, N., Violante, M. D. S., Machuron, F., Ait-Abderrahim, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26741048
Bosselaar, S., Dhelin, L., Dautel, E., Titécat, M., Duthoy, S., Stelmaszczyk, M., Delory, N., Violante, M. D. S., Machuron, F., Ait-Abderrahim, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26741045
Immunoprotective and neuroprotective properties of gut microbiome in psoriasis
Yahyapour, A., Najafi, A., Ahmadi, A., & Salarizadeh, N. (2026) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2026.100348
Soliman, M. A., Basem, Y., Mohamed, H., Mansour, S., & Abdelmonem, R. (2025) · International Journal of Clinical Medical Research · doi:10.61466/ijcmr4010002
Li, Y., Chen, Z., Huo, R., Huang, P., Zhang, C., Zhao, J., 田丰伟, Zhai, Q., & Zhang, C. (2026) · Food Nutrition · doi:10.1016/j.fnutr.2026.100056
Broshtilova, V., Vasilevski, I., Velevska, Y., Yungareva, I., Petkova, Y., & Márina, S. S. (2026) · International Journal of Clinical Dermatology · doi:10.11648/j.ijcd.20260901.13
Chiou, Y., Chiu, T.-Y., & Chen, M.-J. (2026) · Nutrients · doi:10.3390/nu18071107
“Six studies provided data of the change in IL-6 levels [28,31,35–38].”
The Gut-Brain Axis—From Science to Clinical Practice
Quigley, E. M. M. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.100975
Self-citationBiotics: The Food Ingredients Supporting the Intestinal Microbiota and Immune System in Psoriasis
Biasi, J. D., Giménez‐Bastida, J. A., & Krupa‐Kozak, U. (2026) · Nutrition Reviews · doi:10.1093/nutrit/nuaf252
Huang, S.-Q., Gao, X.-P., Liang, H., Feng, Y.-H., Huang, H.-K., Li, Y., Cheng, P.-L., Xie, J., Lu, C.-J., He, G.-H., et al. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05339-3
“…such as Bifidobacterium infantis 35,624, exhibit anti-inflammatory properties in humans, other species or strains (e.g., adult-type B. adolescentis or specific B. bifidum isolates) can induce pro-inflammatory cytokine production in vitro or correlate with allergic phenotypes in infants [40–42].”
Probiotics unveiled: bridging general health benefits to the era of precision medicine
Ullah, M., Rizwan, M., Waheed, M. I., Alam, M. S., Jan, S. U., Raza, A., Shahid, M. F., Andoh, V., & Chen, Y. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-05143-1
“Probiotics selected for the treatment of specific conditions, such as Lactobacillus plantarum 299v and Bifidobacterium infantis 35,624, are effective due to their ability to diminish gut inflammation (Groeger et”
Gut microbiome-immune-metabolic axis in fatigue: mechanistic insights and food science approaches
Kim, J., Son, B., Yoo, W., & Shin, H. (2026) · Food Science and Biotechnology · doi:10.1007/s10068-026-02282-x
“Similarly, Groeger et al. (2013) reported that Bifidobacterium infantis 35,624 reduced inflammatory markers in some subject groups, including CFS patients.”
Preidis, G. A., Berčík, P., Marette, A., O’Mahony, L., Sperandio, V., & Quigley, E. M. M. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2728828
Self-citationJafari, A., Karimzadeh‐Soureshjani, E., Kiani-Shamsabadi, D., Mohammadpour, H., & Mardani, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29835-6.00004-6
Ma, J., Jin, J., Wang, X., He, Y., Zhang, L., Wang, J., Sun, Y., Du, P., Zhang, G., Liu, L., et al. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.110355
Metadata
- Authors
- Groeger, D., O’Mahony, L., Murphy, E. F., Bourke, J. F., Dinan, T. G., Kiely, B., Shanahan, F., & Quigley, E. M. M.
- Affiliations
- Alimentary Health (Ireland) (IE)
- University of Zurich (CH)
- South Infirmary Victoria University Hospital (IE)
- University College Cork (IE)
- Corresponding author
- Quigley, Eamonn M.M.
- Venue
- Gut Microbes
- Publisher
- Informa UK Limited
- Published
- 2013-07-12
- Volume
- 4
- Issue
- 4
- Pages
- 325-339
- ISSN
- 1949-0976 (ISSN-L)
- 1949-0984
- PMC
- PMC3744517
- OpenAlex
- W2056812430
- Cited by
- 448
- References
- 57
- Citations by year
- 2026: 16 · 2025: 52 · 2024: 54 · 2023: 52 · 2022: 56 · 2021: 40 · 2020: 29 · 2019: 36 · 2018: 28 · 2017: 30 · 2016: 16 · 2015: 21 · 2014: 15 · 2013: 3
- FWCI
- 27.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut Microbes (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- probiotics, immunomodulation, ulcerative colitis, chronic fatigue syndrome, psoriasis, systemic inflammation, C-reactive protein, TNF-α, interleukin-6, peripheral blood mononuclear cells, gut microbiota
- MeSH terms
- Administration, Oral, Adolescent, Adult, Aged, Bifidobacterium, C-Reactive Protein, Colitis, Ulcerative, Double-Blind Method, Female, Humans, Immunosuppression Therapy, Male, Middle Aged, Placebos, Psoriasis, Fatigue Syndrome, Chronic, Cytokines, Treatment Outcome, Probiotics, Gastrointestinal Tract, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
